Nu Skin: Patience Is Still Advised
Source: SeekingAlpha
2026-02-25 11:49:00 ET
Heading into an important year, there is a case on paper for Nu Skin Enterprises ( NUS ) stock. Shares are cheap, trading in the range of 3x adjusted EBITDA for 2026. Guidance for this year does seem to have disappointed, sending shares lower, but margins appear set to expand, and the company expects revenue growth to turn positive toward the tail end of the year....
Read the full article on Seeking Alpha
For further details see:
Nu Skin: Patience Is Still Advised
MEDIFAST INC
NASDAQ: MED
MED Trading
2.71% G/L:
$10.805 Last:
59,177 Volume:
$10.58 Open:
MED Latest News
February 20, 2026 08:30:00 am
Scientific Evidence Demonstrates OPTAVIA®'s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients
February 17, 2026 04:05:00 pm
Medifast Announces Fourth Quarter and Full Year 2025 Financial Results
MED Stock Data
$125,190,599
10,672,526
2.58%
34
N/A
Personal Services
Consumer Discretionary
US
Baltimore
